The Bell2Bell (B2B) Podcast

Bell2Bell’s latest podcast features Bruce Nurse, Head of Investor Relations for Vision Marine Technologies Inc. (NASDAQ: VMAR), a global leader and innovator within the performance electric recreational boating industry.

To begin the interview, Nurse introduced Vision Marine Technologies and its business model.

“Our objective here – our mission if you like – is really to disrupt the traditional boating industry by transforming the boating experience with electric power,” Nurse said. “We all see what's happening with the auto industry, with electrification of our vehicles. Every auto manufacturer now has an option for the consumer to drive electric, but we haven't seen this on the water.”

Bell2Bell’s latest podcast features Bruce Nurse, Head of Investor Relations for Vision Marine Technologies Inc. (NASDAQ: VMAR), a global leader and innovator within the performance electric recreational boating industry.

To begin the interview, Nurse introduced Vision Marine Technologies and its business model.

“Our objective here – our mission if you like – is really to disrupt the traditional boating industry by transforming the boating experience with electric power,” Nurse said. “We all see what's happening with the auto industry, with electrification of our vehicles. Every auto manufacturer now has an option for the consumer to drive electric, but we haven't seen this on the water.”

Bell2Bell’s latest podcast features Mariano Soria, General Manager of Turbo Energy S.A., a leading photovoltaic energy storage technology company based in Valencia, Spain.

To begin the interview, Soria introduced Turbo Energy and its business model.

“Turbo Energy is part of a group with more than 20 years of experience in photovoltaic energy,” Soria said. “The company itself was born 10 years ago with the aim of introducing disruptive storage technology, mainly for off-grid homes that wanted to live with photovoltaic energy. It was the introduction of lithium-ion batteries in Spain, and it was also, for us, the beginning of Turbo Energy's leadership in Spain concerning photovoltaic energy storage.”

Bell2Bell’s latest podcast features Mariano Soria, General Manager of Turbo Energy S.A., a leading photovoltaic energy storage technology company based in Valencia, Spain.

To begin the interview, Soria introduced Turbo Energy and its business model.

“Turbo Energy is part of a group with more than 20 years of experience in photovoltaic energy,” Soria said. “The company itself was born 10 years ago with the aim of introducing disruptive storage technology, mainly for off-grid homes that wanted to live with photovoltaic energy. It was the introduction of lithium-ion batteries in Spain, and it was also, for us, the beginning of Turbo Energy's leadership in Spain concerning photovoltaic energy storage.”

Bell2Bell’s latest podcast features Wa’el Hashad, CEO of Longeveron Inc. (NASDAQ: LGVN), a clinical stage biotechnology company developing cellular therapies for life-threatening and chronic aging-related conditions such as hypoplastic left heart syndrome (HLHS), Alzheimer’s disease and Aging-related Frailty.

To begin the interview, Hashad introduced Longeveron and its business model.

“Longeveron is a cell therapy-based biotech company. It was established in 2014 as a spin-off from a technology that was developed at the University of Miami School of Medicine by a renowned scientist and cardiologist, Dr. Josh Hare,” Hashad said. “Josh has been working since he graduated medical school… on trying to help patients regenerate their heart muscles after heart attacks. He continued to use stem cells – specifically mesenchymal stem cells, or medicinal signaling cells – to try to develop medicines that may help patients have a better outcome after heart attacks and so on.”

Bell2Bell’s latest podcast features Wa’el Hashad, CEO of Longeveron Inc. (NASDAQ: LGVN), a clinical stage biotechnology company developing cellular therapies for life-threatening and chronic aging-related conditions such as hypoplastic left heart syndrome (HLHS), Alzheimer’s disease and Aging-related Frailty.

To begin the interview, Hashad introduced Longeveron and its business model.

“Longeveron is a cell therapy-based biotech company. It was established in 2014 as a spin-off from a technology that was developed at the University of Miami School of Medicine by a renowned scientist and cardiologist, Dr. Josh Hare,” Hashad said. “Josh has been working since he graduated medical school… on trying to help patients regenerate their heart muscles after heart attacks. He continued to use stem cells – specifically mesenchymal stem cells, or medicinal signaling cells – to try to develop medicines that may help patients have a better outcome after heart attacks and so on.”

In this engaging episode, David Hough shared key updates following PaxMedica's recent meeting with the FDA, highlighting pivotal achievements such as:

• FDA discussion of PaxMedica's data from the PAX-HAT 301 Study and comprehensive nonclinical programs.
• PAX-HAT-301 study confirmed as positive evidence for African Sleeping Sickness treatment, expected to result in substantial time and resource savings for PaxMedica.
• FDA acknowledgment of PaxMedica's comprehensive nonclinical program, including safety pharmacology, ADME, and toxicology studies.
• Waivers granted for the thorough QT/QTc studies, affirming data relevance to the patient population.
• 2024 NDA submission anticipation underscores PaxMedica's commitment to neglected tropical disease treatments.

In this engaging episode, David Hough shared key updates following PaxMedica's recent meeting with the FDA, highlighting pivotal achievements such as:

• FDA discussion of PaxMedica's data from the PAX-HAT 301 Study and comprehensive nonclinical programs.
• PAX-HAT-301 study confirmed as positive evidence for African Sleeping Sickness treatment, expected to result in substantial time and resource savings for PaxMedica.
• FDA acknowledgment of PaxMedica's comprehensive nonclinical program, including safety pharmacology, ADME, and toxicology studies.
• Waivers granted for the thorough QT/QTc studies, affirming data relevance to the patient population.
• 2024 NDA submission anticipation underscores PaxMedica's commitment to neglected tropical disease treatments.

Bell2Bell’s latest podcast features Brian J. Esposito, CEO of Diamond Lake Minerals Inc. (OTC: DLMI), a multi-strategy operating company offering traditional investors an entry point to the future of digital securities.

To begin the interview, Esposito discussed DLMI’s business model and operating markets.

“The best way I can describe what we’re building here at DLMI is an old-school General Electric/Berkshire Hathaway approach where we’re going to have an umbrella holding company of all of these wonderful subsidiaries across multiple industries,” Esposito said. “Think of us as an industry-agnostic holding umbrella company with wonderful entities that we build, start or acquire. The idea is strong, consistent earnings; shareholder value; and sharing those earnings with our shareholders through strong, consistent dividend distribution. I’m a strong believer that this is what’s needed in the market… I’m proud to be here as the CEO since late August. I’m proud of the accomplishments that we’ve achieved over the past few months, and the global support that we have is quite exceptional.”

Join IBN’s Stuart Smith and Brian J. Esposito, CEO of Diamond Lake Minerals Inc. (OTC: DLMI), to learn more about how the company’s leadership team, including President Michael Reynolds and Senior Transaction and Investment Executive Jon Karas, is working to drive growth, earnings and shareholder value in the months to come.

To hear the episode and subscribe for future podcasts, visit https://podcast.bell2bell.com.

Bell2Bell’s latest podcast features Brian J. Esposito, CEO of Diamond Lake Minerals Inc. (OTC: DLMI), a multi-strategy operating company offering traditional investors an entry point to the future of digital securities.

To begin the interview, Esposito discussed DLMI’s business model and operating markets.

“The best way I can describe what we’re building here at DLMI is an old-school General Electric/Berkshire Hathaway approach where we’re going to have an umbrella holding company of all of these wonderful subsidiaries across multiple industries,” Esposito said. “Think of us as an industry-agnostic holding umbrella company with wonderful entities that we build, start or acquire. The idea is strong, consistent earnings; shareholder value; and sharing those earnings with our shareholders through strong, consistent dividend distribution. I’m a strong believer that this is what’s needed in the market… I’m proud to be here as the CEO since late August. I’m proud of the accomplishments that we’ve achieved over the past few months, and the global support that we have is quite exceptional.”

Join IBN’s Stuart Smith and Brian J. Esposito, CEO of Diamond Lake Minerals Inc. (OTC: DLMI), to learn more about how the company’s leadership team, including President Michael Reynolds and Senior Transaction and Investment Executive Jon Karas, is working to drive growth, earnings and shareholder value in the months to come.

To hear the episode and subscribe for future podcasts, visit https://podcast.bell2bell.com.